Related Experiment Video

Updated: May 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Rac signaling in breast cancer: a tale of GEFs and GAPs

Eva Wertheimer1, Alvaro Gutierrez-Uzquiza1, Cinthia Rosemblit1

  • 1Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA.

Cellular Signalling
|September 7, 2011
PubMed

Insights

Rac GTPases are crucial for cell functions and are implicated in cancer. The study identifies P-Rex1 as a key mediator in breast cancer, suggesting it as a potential therapeutic target.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Rac GTPases regulate fundamental cellular processes like motility, adhesion, and proliferation, and are frequently dysregulated in cancer.
  • In breast cancer, Rac1 signaling is a downstream effector of ErbB receptors, mediating migratory responses.
  • P-Rex1, a Rac-specific Guanine nucleotide Exchange Factor (GEF), has emerged as a critical mediator of Rac1 activity.

Purpose of the Study:

  • To investigate the role of P-Rex1 in mediating Rac1 signaling in breast cancer.
  • To understand how P-Rex1 integrates signals from receptor tyrosine kinases and G-protein-coupled receptors.
  • To evaluate P-Rex1 as a potential therapeutic target in breast cancer.

Main Methods:

  • Analysis of Rac signaling pathways in breast cancer cells.
  • Investigating the activation mechanisms of P-Rex1 by PI3K products and Gβγ subunits.
  • Assessing P-Rex1 expression levels in human breast tumors.

Main Results:

  • P-Rex1 is activated by PIP3 and Gβγ subunits, integrating signals from ErbB receptors and GPCRs.
  • P-Rex1 is highly overexpressed in human luminal breast tumors, particularly those positive for ErbB2 and estrogen receptor (ER).
  • The P-Rex1/Rac pathway is essential for Rac1 responses in breast cancer cells.

Conclusions:

  • P-Rex1 is a key mediator of Rac1 signaling in breast cancer, integrating signals from multiple oncogenic pathways.
  • Overexpression of P-Rex1 in specific breast tumor subtypes highlights its clinical relevance.
  • The P-Rex1/Rac signaling pathway presents a promising therapeutic target for breast cancer treatment.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...